Brugarolas, Pedro http://orcid.org/0000-0002-7455-2743
Wilks, Moses Q.
Noel, Jacqueline
Kaiser, Julia-Ann
Vesper, Danielle R.
Ramos-Torres, Karla M.
Guehl, Nicolas J.
Macdonald-Soccorso, Marina T.
Sun, Yang
Rice, Peter A.
Yokell, Daniel L.
Lim, Ruth
Normandin, Marc D.
El Fakhri, Georges
Funding for this research was provided by:
National Institute of Neurological Disorders and Stroke (R01NS114066)
National Institute of Biomedical Imaging and Bioengineering (P41EB022544)
NIH Office of the Director (S10OD026987)
Article History
Received: 19 May 2022
Accepted: 19 September 2022
First Online: 5 October 2022
Declarations
:
: PB has a financial interest in the Fuzionaire Diagnostics and the University of Chicago. PB is a named inventor of patents related to [<sup>18</sup>F]3F4AP owned by the University of Chicago and licensed to the Fuzionaire Diagnostics. PB’s interests were reviewed and are managed by the MGH and Mass General Brigham in accordance with their conflict of interest policies. The other authors declare no competing interests.